Rhythm Pharmaceuticals Inc (NAS:RYTM)
$ 55.59 -0.95 (-1.68%) Market Cap: 3.47 Bil Enterprise Value: 3.14 Bil PE Ratio: 0 PB Ratio: 308.96 GF Score: 58/100

Rhythm Pharmaceuticals, Inc. - Special Call Transcript

Jan 26, 2021 / 01:00PM GMT
Release Date Price: $34.03 (-13.17%)
Hunter C. Smith
Rhythm Pharmaceuticals, Inc. - CFO, Treasurer & Secretary

Good morning. I'm Hunter Smith, Chief Financial Officer of Rhythm Pharmaceuticals, and I want to thank you for joining us as we discuss our proof-of-concept data from the exploratory Phase II Basket Study and provide an update on our sequencing efforts.

Please note the press release issued earlier today and presentation we're using for this conference call are both available online in the Investors and Media section of our website: rhythmtx.com. Before we begin, I'd like to remind everyone that there will be forward-looking statements made on this call. Actual events or results could differ materially from those expressed or implied by any forward-looking statements, such as a result of various risks, uncertainties and other factors, including those set forth in the Risk Factors section of our Forms 10-K or 10-Q or any other filings that we make with the SEC in the future. In addition, any forward-looking statements made on this call represent our views only as of today and should not be relied upon as representing our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot